Symbol:
Plagl2
Name:
PLAG1 like zinc finger 2
RGD ID:
1307999
Description:
Predicted to enable DNA-binding transcription activator activity, RNA polymerase II-specific and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to act upstream of or within several processes, including chylomicron assembly; positive regulation of intrinsic apoptotic signaling pathway; and positive regulation of transcription by RNA polymerase II. Predicted to be active in nucleus. Orthologous to human PLAGL2 (PLAG1 like zinc finger 2); INTERACTS WITH 2,3,7,8-tetrachlorodibenzodioxine; 2,3,7,8-Tetrachlorodibenzofuran; acrylamide.
Type:
protein-coding
RefSeq Status:
VALIDATED
Previously known as:
LOC296281; pleiomorphic adenoma gene-like 2; zinc finger protein PLAGL2
RGD Orthologs
Alliance Orthologs
More Info
more info ...
More Info
Latest Assembly:
GRCr8 - GRCr8 Assembly
Position:
Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCr8 3 162,155,554 - 162,168,748 (-) NCBI GRCr8 mRatBN7.2 3 141,695,322 - 141,708,516 (-) NCBI mRatBN7.2 mRatBN7.2 mRatBN7.2 Ensembl 3 141,695,322 - 141,708,503 (-) Ensembl mRatBN7.2 Ensembl UTH_Rnor_SHR_Utx 3 145,599,998 - 145,613,192 (-) NCBI Rnor_SHR UTH_Rnor_SHR_Utx UTH_Rnor_SHRSP_BbbUtx_1.0 3 154,183,795 - 154,196,989 (-) NCBI Rnor_SHRSP UTH_Rnor_SHRSP_BbbUtx_1.0 UTH_Rnor_WKY_Bbb_1.0 3 151,922,925 - 151,936,119 (-) NCBI Rnor_WKY UTH_Rnor_WKY_Bbb_1.0 Rnor_6.0 3 148,709,564 - 148,722,777 (-) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 3 148,709,531 - 148,722,742 (-) Ensembl Rnor6.0 rn6 Rnor6.0 Rnor_5.0 3 155,374,832 - 155,388,034 (+) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 RGSC_v3.4 3 143,578,877 - 143,592,055 (-) NCBI RGSC3.4 RGSC_v3.4 rn4 RGSC3.4 RGSC_v3.1 3 143,488,233 - 143,497,675 (-) NCBI Celera 3 140,441,550 - 140,454,733 (-) NCBI Celera Cytogenetic Map 3 q41 NCBI
JBrowse:
View Region in Genome Browser (JBrowse)
Model
Only show annotations with direct experimental evidence (0 objects hidden)
Plagl2 Rat 17alpha-ethynylestradiol affects expression ISO RGD:1317515 6480464 Ethinyl Estradiol affects the expression of PLAGL2 mRNA CTD PMID:17555576 Plagl2 Rat 17beta-estradiol increases expression ISO RGD:1317514 6480464 Estradiol results in increased expression of PLAGL2 mRNA CTD PMID:23019147 Plagl2 Rat 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1317515 6480464 Tetrachlorodibenzodioxin affects the expression of PLAGL2 mRNA CTD PMID:21570461 Plagl2 Rat 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of PLAGL2 mRNA CTD PMID:33387578 Plagl2 Rat 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of PLAGL2 mRNA CTD PMID:32109520 Plagl2 Rat 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1317515 6480464 Tetrachlorodibenzodioxin results in increased expression of PLAGL2 mRNA CTD PMID:19465110 Plagl2 Rat 2,3,7,8-Tetrachlorodibenzofuran increases expression EXP 6480464 2,3,7,8-tetrachlorodibenzofuran results in increased expression of PLAGL2 mRNA CTD PMID:32109520 Plagl2 Rat 2-methylcholine affects expression ISO RGD:1317514 6480464 beta-methylcholine affects the expression of PLAGL2 mRNA CTD PMID:21179406 Plagl2 Rat 4,4'-diaminodiphenylmethane decreases expression ISO RGD:1317515 6480464 4,4'-diaminodiphenylmethane results in decreased expression of PLAGL2 mRNA CTD PMID:18648102 Plagl2 Rat 4,4'-sulfonyldiphenol decreases expression ISO RGD:1317515 6480464 bisphenol S results in decreased expression of PLAGL2 mRNA CTD PMID:39298647 Plagl2 Rat 4-hydroxynon-2-enal decreases expression ISO RGD:1317515 6480464 4-hydroxy-2-nonenal results in decreased expression of PLAGL2 mRNA CTD PMID:19191707 Plagl2 Rat 4-hydroxyphenyl retinamide increases expression ISO RGD:1317515 6480464 Fenretinide results in increased expression of PLAGL2 mRNA CTD PMID:28973697 Plagl2 Rat acrylamide decreases expression EXP 6480464 Acrylamide results in decreased expression of PLAGL2 mRNA CTD PMID:28959563 Plagl2 Rat acrylamide increases expression ISO RGD:1317514 6480464 Acrylamide results in increased expression of PLAGL2 mRNA CTD PMID:32763439 Plagl2 Rat aflatoxin B1 increases expression ISO RGD:1317514 6480464 Aflatoxin B1 results in increased expression of PLAGL2 mRNA CTD PMID:22100608 Plagl2 Rat aflatoxin B1 decreases methylation ISO RGD:1317514 6480464 Aflatoxin B1 results in decreased methylation of PLAGL2 gene CTD PMID:27153756 Plagl2 Rat aflatoxin B1 increases expression ISO RGD:1317515 6480464 Aflatoxin B1 results in increased expression of PLAGL2 mRNA CTD PMID:19770486 Plagl2 Rat all-trans-retinoic acid increases expression ISO RGD:1317514 6480464 Tretinoin results in increased expression of PLAGL2 mRNA CTD PMID:33167477 Plagl2 Rat arsenite(3-) increases methylation ISO RGD:1317514 6480464 arsenite results in increased methylation of PLAGL2 promoter CTD PMID:23974009 Plagl2 Rat arsenous acid increases expression ISO RGD:1317514 6480464 Arsenic Trioxide results in increased expression of PLAGL2 mRNA CTD PMID:20458559 Plagl2 Rat benzo[a]pyrene decreases expression ISO RGD:1317515 6480464 Benzo(a)pyrene results in decreased expression of PLAGL2 mRNA CTD PMID:22228805 Plagl2 Rat benzo[a]pyrene increases expression ISO RGD:1317514 6480464 Benzo(a)pyrene results in increased expression of PLAGL2 mRNA CTD PMID:32234424 Plagl2 Rat benzo[a]pyrene affects methylation ISO RGD:1317514 6480464 Benzo(a)pyrene affects the methylation of PLAGL2 5' UTR CTD PMID:27901495 Plagl2 Rat bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of PLAGL2 mRNA CTD PMID:25181051|PMID:34947998 Plagl2 Rat bisphenol A increases methylation ISO RGD:1317515 6480464 bisphenol A results in increased methylation of PLAGL2 promoter CTD PMID:27312807 Plagl2 Rat bisphenol A increases methylation EXP 6480464 bisphenol A results in increased methylation of PLAGL2 gene CTD PMID:28505145 Plagl2 Rat bisphenol A affects methylation ISO RGD:1317515 6480464 bisphenol A affects the methylation of PLAGL2 promoter CTD PMID:27334623 Plagl2 Rat buta-1,3-diene decreases expression ISO RGD:1317515 6480464 1,3-butadiene results in decreased expression of PLAGL2 mRNA CTD PMID:29038090 Plagl2 Rat C60 fullerene increases expression EXP 6480464 fullerene C60 results in increased expression of PLAGL2 mRNA CTD PMID:19167457 Plagl2 Rat cadmium atom multiple interactions ISO RGD:1317514 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of PLAGL2 more ... CTD PMID:35301059 Plagl2 Rat cadmium dichloride multiple interactions ISO RGD:1317514 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of PLAGL2 more ... CTD PMID:35301059 Plagl2 Rat CGP 52608 multiple interactions ISO RGD:1317514 6480464 CGP 52608 promotes the reaction [RORA protein binds to PLAGL2 gene] CTD PMID:28238834 Plagl2 Rat chrysene increases expression ISO RGD:1317515 6480464 chrysene results in increased expression of PLAGL2 mRNA CTD PMID:26377693 Plagl2 Rat cisplatin decreases expression ISO RGD:1317514 6480464 Cisplatin results in decreased expression of PLAGL2 mRNA CTD PMID:27594783 Plagl2 Rat cobalt dichloride increases expression EXP 6480464 cobaltous chloride results in increased expression of PLAGL2 mRNA CTD PMID:24386269 Plagl2 Rat copper atom increases expression EXP 6480464 Copper deficiency results in increased expression of PLAGL2 mRNA CTD PMID:26033743 Plagl2 Rat copper(0) increases expression EXP 6480464 Copper deficiency results in increased expression of PLAGL2 mRNA CTD PMID:26033743 Plagl2 Rat copper(II) sulfate decreases expression ISO RGD:1317514 6480464 Copper Sulfate results in decreased expression of PLAGL2 mRNA CTD PMID:19549813 Plagl2 Rat coumarin decreases phosphorylation ISO RGD:1317514 6480464 coumarin results in decreased phosphorylation of PLAGL2 protein CTD PMID:35688186 Plagl2 Rat Cuprizon increases expression EXP 6480464 Cuprizone results in increased expression of PLAGL2 mRNA CTD PMID:26577399 Plagl2 Rat cyclosporin A decreases expression ISO RGD:1317514 6480464 Cyclosporine results in decreased expression of PLAGL2 mRNA CTD PMID:25562108 Plagl2 Rat desferrioxamine B multiple interactions ISO RGD:1317515 6480464 Deferoxamine results in increased expression of and affects the localization of PLAGL2 protein CTD PMID:11832486 Plagl2 Rat diarsenic trioxide increases expression ISO RGD:1317514 6480464 Arsenic Trioxide results in increased expression of PLAGL2 mRNA CTD PMID:20458559 Plagl2 Rat dicrotophos increases expression ISO RGD:1317514 6480464 dicrotophos results in increased expression of PLAGL2 mRNA CTD PMID:28302478 Plagl2 Rat dieldrin affects expression EXP 6480464 Dieldrin affects the expression of PLAGL2 mRNA CTD PMID:22546817 Plagl2 Rat dorsomorphin multiple interactions ISO RGD:1317514 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased more ... CTD PMID:27188386 Plagl2 Rat fenthion increases expression ISO RGD:1317515 6480464 Fenthion results in increased expression of PLAGL2 mRNA CTD PMID:34813904 Plagl2 Rat gentamycin decreases expression EXP 6480464 Gentamicins results in decreased expression of PLAGL2 mRNA CTD PMID:33387578 Plagl2 Rat lead(0) affects expression ISO RGD:1317514 6480464 Lead affects the expression of PLAGL2 mRNA CTD PMID:28903495 Plagl2 Rat leflunomide decreases expression ISO RGD:1317514 6480464 leflunomide results in decreased expression of PLAGL2 mRNA CTD PMID:28988120 Plagl2 Rat menadione affects expression ISO RGD:1317514 6480464 Vitamin K 3 affects the expression of PLAGL2 mRNA CTD PMID:20044591 Plagl2 Rat methylmercury chloride decreases expression ISO RGD:1317514 6480464 methylmercuric chloride results in decreased expression of PLAGL2 mRNA CTD PMID:28001369 Plagl2 Rat nickel atom increases expression ISO RGD:1317514 6480464 Nickel results in increased expression of PLAGL2 mRNA CTD PMID:25583101 Plagl2 Rat poly(I:C) multiple interactions ISO RGD:1317514 6480464 [TL8-506 co-treated with Poly I-C] results in increased expression of PLAGL2 mRNA CTD PMID:35688559 Plagl2 Rat protein kinase inhibitor multiple interactions ISO RGD:1317514 6480464 Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in increased expression of PLAGL2 mRNA] CTD PMID:28003376 Plagl2 Rat rotenone increases expression ISO RGD:1317515 6480464 Rotenone results in increased expression of PLAGL2 mRNA CTD PMID:32937126 Plagl2 Rat SB 431542 multiple interactions ISO RGD:1317514 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased more ... CTD PMID:27188386 Plagl2 Rat sodium arsenite decreases expression ISO RGD:1317515 6480464 sodium arsenite results in decreased expression of PLAGL2 mRNA CTD PMID:37682722 Plagl2 Rat succimer multiple interactions ISO RGD:1317515 6480464 [Succimer binds to Magnetite Nanoparticles] which results in increased expression of PLAGL2 mRNA; [Succimer co-treated more ... CTD PMID:21641980|PMID:26378955 Plagl2 Rat sunitinib increases expression ISO RGD:1317514 6480464 Sunitinib results in increased expression of PLAGL2 mRNA CTD PMID:31533062 Plagl2 Rat temozolomide decreases expression ISO RGD:1317514 6480464 Temozolomide results in decreased expression of PLAGL2 mRNA CTD PMID:31758290 Plagl2 Rat testosterone increases expression ISO RGD:1317515 6480464 Testosterone deficiency results in increased expression of PLAGL2 mRNA CTD PMID:33848595 Plagl2 Rat thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of PLAGL2 mRNA CTD PMID:34492290 Plagl2 Rat titanium dioxide increases methylation ISO RGD:1317515 6480464 titanium dioxide results in increased methylation of PLAGL2 promoter alternative form CTD PMID:35295148 Plagl2 Rat trichostatin A decreases expression ISO RGD:1317514 6480464 trichostatin A results in decreased expression of PLAGL2 mRNA CTD PMID:24935251|PMID:26272509 Plagl2 Rat trichostatin A multiple interactions ISO RGD:1317514 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased more ... CTD PMID:27188386 Plagl2 Rat triptonide decreases expression ISO RGD:1317515 6480464 triptonide results in decreased expression of PLAGL2 mRNA CTD PMID:33045310 Plagl2 Rat valproic acid decreases methylation ISO RGD:1317514 6480464 Valproic Acid results in decreased methylation of PLAGL2 gene CTD PMID:29154799 Plagl2 Rat valproic acid multiple interactions ISO RGD:1317514 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased more ... CTD PMID:27188386 Plagl2 Rat valproic acid decreases expression ISO RGD:1317514 6480464 Valproic Acid results in decreased expression of PLAGL2 mRNA CTD PMID:23179753|PMID:26272509|PMID:28001369 Plagl2 Rat zinc atom multiple interactions ISO RGD:1317514 6480464 [PCI 5002 co-treated with Zinc] results in increased expression of PLAGL2 mRNA CTD PMID:18593933 Plagl2 Rat zinc(0) multiple interactions ISO RGD:1317514 6480464 [PCI 5002 co-treated with Zinc] results in increased expression of PLAGL2 mRNA CTD PMID:18593933
17alpha-ethynylestradiol (ISO) 17beta-estradiol (ISO) 2,3,7,8-tetrachlorodibenzodioxine (EXP,ISO) 2,3,7,8-Tetrachlorodibenzofuran (EXP) 2-methylcholine (ISO) 4,4'-diaminodiphenylmethane (ISO) 4,4'-sulfonyldiphenol (ISO) 4-hydroxynon-2-enal (ISO) 4-hydroxyphenyl retinamide (ISO) acrylamide (EXP,ISO) aflatoxin B1 (ISO) all-trans-retinoic acid (ISO) arsenite(3-) (ISO) arsenous acid (ISO) benzo[a]pyrene (ISO) bisphenol A (EXP,ISO) buta-1,3-diene (ISO) C60 fullerene (EXP) cadmium atom (ISO) cadmium dichloride (ISO) CGP 52608 (ISO) chrysene (ISO) cisplatin (ISO) cobalt dichloride (EXP) copper atom (EXP) copper(0) (EXP) copper(II) sulfate (ISO) coumarin (ISO) Cuprizon (EXP) cyclosporin A (ISO) desferrioxamine B (ISO) diarsenic trioxide (ISO) dicrotophos (ISO) dieldrin (EXP) dorsomorphin (ISO) fenthion (ISO) gentamycin (EXP) lead(0) (ISO) leflunomide (ISO) menadione (ISO) methylmercury chloride (ISO) nickel atom (ISO) poly(I:C) (ISO) protein kinase inhibitor (ISO) rotenone (ISO) SB 431542 (ISO) sodium arsenite (ISO) succimer (ISO) sunitinib (ISO) temozolomide (ISO) testosterone (ISO) thioacetamide (EXP) titanium dioxide (ISO) trichostatin A (ISO) triptonide (ISO) valproic acid (ISO) zinc atom (ISO) zinc(0) (ISO)
Plagl2 Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCr8 3 162,155,554 - 162,168,748 (-) NCBI GRCr8 mRatBN7.2 3 141,695,322 - 141,708,516 (-) NCBI mRatBN7.2 mRatBN7.2 mRatBN7.2 Ensembl 3 141,695,322 - 141,708,503 (-) Ensembl mRatBN7.2 Ensembl UTH_Rnor_SHR_Utx 3 145,599,998 - 145,613,192 (-) NCBI Rnor_SHR UTH_Rnor_SHR_Utx UTH_Rnor_SHRSP_BbbUtx_1.0 3 154,183,795 - 154,196,989 (-) NCBI Rnor_SHRSP UTH_Rnor_SHRSP_BbbUtx_1.0 UTH_Rnor_WKY_Bbb_1.0 3 151,922,925 - 151,936,119 (-) NCBI Rnor_WKY UTH_Rnor_WKY_Bbb_1.0 Rnor_6.0 3 148,709,564 - 148,722,777 (-) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 3 148,709,531 - 148,722,742 (-) Ensembl Rnor6.0 rn6 Rnor6.0 Rnor_5.0 3 155,374,832 - 155,388,034 (+) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 RGSC_v3.4 3 143,578,877 - 143,592,055 (-) NCBI RGSC3.4 RGSC_v3.4 rn4 RGSC3.4 RGSC_v3.1 3 143,488,233 - 143,497,675 (-) NCBI Celera 3 140,441,550 - 140,454,733 (-) NCBI Celera Cytogenetic Map 3 q41 NCBI
PLAGL2 Human Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCh38 20 32,192,504 - 32,207,743 (-) NCBI GRCh38 GRCh38 hg38 GRCh38 GRCh38.p14 Ensembl 20 32,192,504 - 32,207,743 (-) Ensembl GRCh38 hg38 GRCh38 GRCh37 20 30,780,307 - 30,795,546 (-) NCBI GRCh37 GRCh37 hg19 GRCh37 Build 36 20 30,243,968 - 30,259,207 (-) NCBI NCBI36 Build 36 hg18 NCBI36 Build 34 20 30,243,967 - 30,259,192 NCBI Celera 20 27,536,659 - 27,551,898 (-) NCBI Celera Cytogenetic Map 20 q11.21 NCBI HuRef 20 27,568,818 - 27,584,057 (-) NCBI HuRef CHM1_1 20 30,684,153 - 30,699,392 (-) NCBI CHM1_1 T2T-CHM13v2.0 20 33,916,427 - 33,931,666 (-) NCBI T2T-CHM13v2.0
Plagl2 Mouse Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCm39 2 153,069,689 - 153,083,278 (-) NCBI GRCm39 GRCm39 mm39 GRCm39 Ensembl 2 153,069,679 - 153,083,346 (-) Ensembl GRCm39 Ensembl GRCm38 2 153,227,769 - 153,241,358 (-) NCBI GRCm38 GRCm38 mm10 GRCm38 GRCm38.p6 Ensembl 2 153,227,759 - 153,241,426 (-) Ensembl GRCm38 mm10 GRCm38 MGSCv37 2 153,053,505 - 153,067,094 (-) NCBI GRCm37 MGSCv37 mm9 NCBIm37 MGSCv36 2 152,919,210 - 152,932,799 (-) NCBI MGSCv36 mm8 Celera 2 159,055,337 - 159,068,930 (-) NCBI Celera Cytogenetic Map 2 H1 NCBI cM Map 2 75.41 NCBI
Plagl2 Chinchilla Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl ChiLan1.0 Ensembl NW_004955422 28,839,020 - 28,847,255 (+) Ensembl ChiLan1.0 ChiLan1.0 NW_004955422 28,839,021 - 28,847,255 (+) NCBI ChiLan1.0 ChiLan1.0
PLAGL2 Bonobo Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl NHGRI_mPanPan1-v2 21 37,884,835 - 37,900,189 (-) NCBI NHGRI_mPanPan1-v2 NHGRI_mPanPan1 20 37,881,834 - 37,893,276 (-) NCBI NHGRI_mPanPan1 Mhudiblu_PPA_v0 20 28,481,605 - 28,496,903 (-) NCBI Mhudiblu_PPA_v0 Mhudiblu_PPA_v0 panPan3 PanPan1.1 20 29,610,196 - 29,625,442 (-) NCBI panpan1.1 PanPan1.1 panPan2 PanPan1.1 Ensembl 20 29,610,196 - 29,625,442 (-) Ensembl panpan1.1 panPan2
PLAGL2 Dog Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl CanFam3.1 24 21,594,679 - 21,608,728 (-) NCBI CanFam3.1 CanFam3.1 canFam3 CanFam3.1 CanFam3.1 Ensembl 24 21,597,754 - 21,608,696 (-) Ensembl CanFam3.1 canFam3 CanFam3.1 Dog10K_Boxer_Tasha 24 21,239,819 - 21,254,840 (-) NCBI Dog10K_Boxer_Tasha ROS_Cfam_1.0 24 22,280,186 - 22,295,205 (-) NCBI ROS_Cfam_1.0 ROS_Cfam_1.0 Ensembl 24 22,283,224 - 22,295,169 (-) Ensembl ROS_Cfam_1.0 Ensembl UMICH_Zoey_3.1 24 21,558,720 - 21,573,736 (-) NCBI UMICH_Zoey_3.1 UNSW_CanFamBas_1.0 24 21,664,081 - 21,679,089 (-) NCBI UNSW_CanFamBas_1.0 UU_Cfam_GSD_1.0 24 22,094,869 - 22,109,887 (-) NCBI UU_Cfam_GSD_1.0
Plagl2 Squirrel Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl HiC_Itri_2 NW_024408640 170,666,634 - 170,674,632 (-) NCBI HiC_Itri_2 SpeTri2.0 Ensembl NW_004936485 19,101,888 - 19,106,165 (-) Ensembl SpeTri2.0 SpeTri2.0 Ensembl SpeTri2.0 NW_004936485 19,098,000 - 19,106,164 (-) NCBI SpeTri2.0 SpeTri2.0 SpeTri2.0
PLAGL2 Pig Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl Sscrofa11.1 Ensembl 17 35,840,633 - 35,856,440 (-) Ensembl Sscrofa11.1 susScr11 Sscrofa11.1 Sscrofa11.1 17 35,840,624 - 35,856,564 (-) NCBI Sscrofa11.1 Sscrofa11.1 susScr11 Sscrofa11.1 Sscrofa10.2 17 40,743,160 - 40,755,199 (-) NCBI Sscrofa10.2 Sscrofa10.2 susScr3
PLAGL2 Green Monkey Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl ChlSab1.1 2 36,576,001 - 36,590,822 (-) NCBI ChlSab1.1 ChlSab1.1 chlSab2 ChlSab1.1 Ensembl 2 36,575,559 - 36,590,772 (-) Ensembl ChlSab1.1 ChlSab1.1 Ensembl chlSab2 Vero_WHO_p1.0 NW_023666050 90,322,517 - 90,337,356 (+) NCBI Vero_WHO_p1.0 Vero_WHO_p1.0
Plagl2
.
Predicted Target Of
Count of predictions: 446 Count of miRNA genes: 237 Interacting mature miRNAs: 326 Transcripts: ENSRNOT00000068592 Prediction methods: Miranda, Targetscan Result types: miRGate_prediction
2312673 Scl63 Serum cholesterol level QTL 63 0.001 blood cholesterol amount (VT:0000180) serum total cholesterol level (CMO:0000363) 3 98535255 168026850 Rat 1598877 Bp285 Blood pressure QTL 285 1.5 0.03 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 3 120538241 165538241 Rat 1578653 Vnigr3 Vascular neointimal growth QTL 3 3.1 artery morphology trait (VT:0002191) artery neointimal hyperplastic lesion area (CMO:0001414) 3 130656562 169034231 Rat 2302373 Gluco39 Glucose level QTL 39 5.01 blood glucose amount (VT:0000188) blood glucose level area under curve (AUC) (CMO:0000350) 3 98535386 161695835 Rat 1298068 Bp167 Blood pressure QTL 167 0.004 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 3 141074471 169034231 Rat 70216 Cm14 Cardiac mass QTL 14 2.1 heart mass (VT:0007028) heart wet weight (CMO:0000069) 3 31172320 163586636 Rat 2292591 Esta4 Estrogen-induced thymic atrophy QTL 4 thymus mass (VT:0004954) thymus wet weight (CMO:0000855) 3 47233211 147415807 Rat 2298477 Eau4 Experimental allergic uveoretinitis QTL 4 0.0011 uvea integrity trait (VT:0010551) experimental autoimmune uveitis score (CMO:0001504) 3 137398739 169034231 Rat 61335 Bp20 Blood pressure QTL 20 3 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 3 141339236 155617360 Rat 1581568 Rf53 Renal function QTL 53 urine total protein amount (VT:0000032) urine protein excretion rate to body weight ratio (CMO:0001099) 3 56395968 161299569 Rat 1578754 Stresp16 Stress response QTL 16 4 0.001 blood renin amount (VT:0003349) plasma renin activity level (CMO:0000116) 3 112681431 157681431 Rat 1331726 Bp208 Blood pressure QTL 208 3.129 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 3 141339013 162184794 Rat 1300173 Rf11 Renal function QTL 11 3.38 renal blood flow trait (VT:2000006) absolute change in renal blood flow rate (CMO:0001168) 3 121056165 145956249 Rat 9589106 Insul23 Insulin level QTL 23 13.86 0.001 blood insulin amount (VT:0001560) plasma insulin level (CMO:0000342) 3 131635904 169034231 Rat 10755461 Coatc16 Coat color QTL 16 coat/hair pigmentation trait (VT:0010463) pigmented ventral coat/hair area to total ventral coat/hair area ratio (CMO:0001812) 3 122438700 167438700 Rat 8662816 Vetf4 Vascular elastic tissue fragility QTL 4 4 renal artery integrity trait (VT:0010642) number of ruptures of the internal elastic lamina of the renal arteries (CMO:0002563) 3 59242096 157323038 Rat 1559282 Emca5 Estrogen-induced mammary cancer QTL 5 3.9 mammary gland integrity trait (VT:0010552) percentage of study population developing mammary tumors during a period of time (CMO:0000948) 3 43827364 169034231 Rat 1354611 Despr2 Despair related QTL 2 3.03 0.0028 locomotor behavior trait (VT:0001392) amount of time spent in voluntary immobility (CMO:0001043) 3 97084464 142084464 Rat 2303620 Vencon4 Ventilatory control QTL 4 3.9 respiration trait (VT:0001943) tidal volume (CMO:0000222) 3 127162703 168026850 Rat 631841 Niddm39 Non-insulin dependent diabetes mellitus QTL 39 3.36 blood glucose amount (VT:0000188) blood glucose level (CMO:0000046) 3 94856903 159898684 Rat 1576306 Schws3 Schwannoma susceptibility QTL 3 0.001 nervous system integrity trait (VT:0010566) percentage of study population developing trigeminal nerve neurilemmomas during a period of time (CMO:0002017) 3 118839124 163839124 Rat 619618 Rf3 Renal disease susceptibility QTL 3 6.5 0.001 urine albumin amount (VT:0002871) urine albumin excretion rate to body weight ratio (CMO:0001270) 3 107693393 152693393 Rat 1300159 Kidm4 Kidney mass QTL 4 3.83 kidney mass (VT:0002707) right kidney wet weight to body weight ratio (CMO:0001953) 3 121056165 157309487 Rat 5686842 Rf59 Renal function QTL 59 urine albumin amount (VT:0002871) urine albumin excretion rate (CMO:0000757) 3 140069424 146976080 Rat 2301971 Cm71 Cardiac mass QTL 71 4.63 heart left ventricle mass (VT:0007031) heart left ventricle weight (CMO:0000776) 3 41874578 155617519 Rat 2312659 Slep7 Serum leptin concentration QTL 7 0.001 blood leptin amount (VT:0005667) serum leptin level (CMO:0000780) 3 98535255 168026850 Rat 631673 Iddm13 Insulin dependent diabetes mellitus QTL 13 1.3 0.663 blood glucose amount (VT:0000188) plasma glucose level (CMO:0000042) 3 130193298 161695983 Rat 2301970 Bw81 Body weight QTL 81 5.19 body mass (VT:0001259) body weight (CMO:0000012) 3 41874578 155617519 Rat 1581546 Pur13 Proteinuria QTL 13 2.93 0.0335 urine total protein amount (VT:0000032) urine protein excretion rate (CMO:0000759) 3 78196190 146592722 Rat 1578656 Vnigr2 Vascular neointimal growth QTL 2 4.2 artery morphology trait (VT:0002191) lesioned artery residual lumen area (CMO:0001417) 3 130656562 169034231 Rat 8552952 Pigfal13 Plasma insulin-like growth factor 1 level QTL 13 blood insulin-like growth factor amount (VT:0010479) plasma insulin-like growth factor 1 level (CMO:0001299) 3 138799500 169034231 Rat 631541 Bp81 Blood pressure QTL 81 4 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 3 124122556 169034231 Rat 2293087 Iddm27 Insulin dependent diabetes mellitus QTL 27 2.68 blood glucose amount (VT:0000188) blood glucose level (CMO:0000046) 3 97551417 147415807 Rat 2312670 Bw94 Body weight QTL 94 0.01 inguinal fat pad mass (VT:0010424) inguinal fat pad weight to body weight ratio (CMO:0001253) 3 98535255 168026850 Rat
RH136245
Rat Assembly Chr Position (strand) Source JBrowse mRatBN7.2 3 141,695,418 - 141,695,623 (+) MAPPER mRatBN7.2 Rnor_6.0 3 148,709,661 - 148,709,865 NCBI Rnor6.0 Rnor_5.0 3 155,387,732 - 155,387,937 NCBI Rnor5.0 RGSC_v3.4 3 143,578,974 - 143,579,178 UniSTS RGSC3.4 Celera 3 140,441,647 - 140,441,851 UniSTS Cytogenetic Map 3 q41 UniSTS
Click on a value in the shaded box below the category label to view a detailed expression data table for that system.
alimentary part of gastrointestinal system
9
11
49
113
91
90
59
25
59
6
218
97
93
45
60
31
Too many to show, limit is 500. Download them if you would like to view them all.
Ensembl Acc Id:
ENSRNOT00000068592 ⟹ ENSRNOP00000059668
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 3 141,695,322 - 141,708,503 (-) Ensembl Rnor_6.0 Ensembl 3 148,709,564 - 148,722,742 (-) Ensembl
Ensembl Acc Id:
ENSRNOT00000090919 ⟹ ENSRNOP00000071224
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source Rnor_6.0 Ensembl 3 148,709,531 - 148,722,710 (-) Ensembl
Ensembl Acc Id:
ENSRNOT00000097371 ⟹ ENSRNOP00000077451
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 3 141,698,237 - 141,708,503 (-) Ensembl
RefSeq Acc Id:
NM_001401809 ⟹ NP_001388738
RefSeq Status:
VALIDATED
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 3 162,155,554 - 162,168,748 (-) NCBI mRatBN7.2 3 141,695,322 - 141,708,516 (-) NCBI
Ensembl Acc Id:
ENSRNOP00000071224 ⟸ ENSRNOT00000090919
Ensembl Acc Id:
ENSRNOP00000059668 ⟸ ENSRNOT00000068592
Ensembl Acc Id:
ENSRNOP00000077451 ⟸ ENSRNOT00000097371
RefSeq Acc Id:
NP_001388738 ⟸ NM_001401809
- UniProtKB:
A0A0G2JZX7 (UniProtKB/TrEMBL), A6KHU5 (UniProtKB/TrEMBL)
RGD ID: 13692570 Promoter ID: EPDNEW_R3085 Type: multiple initiation site Name: Plagl2_1 Description: PLAG1 like zinc finger 2 SO ACC ID: SO:0000170 Source: EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/ ) Experiment Methods: Single-end sequencing. Position: Rat Assembly Chr Position (strand) Source Rnor_6.0 3 148,722,742 - 148,722,802 EPDNEW
Date
Current Symbol
Current Name
Previous Symbol
Previous Name
Description
Reference
Status
2015-12-23
Plagl2
PLAG1 like zinc finger 2
Plagl2
pleiomorphic adenoma gene-like 2
Nomenclature updated to reflect human and mouse nomenclature
1299863 APPROVED
2008-04-30
Plagl2
pleiomorphic adenoma gene-like 2
Plagl2_predicted
pleiomorphic adenoma gene-like 2 (predicted)
'predicted' is removed
2292626 APPROVED
2005-01-12
Plagl2_predicted
pleiomorphic adenoma gene-like 2 (predicted)
Symbol and Name status set to approved
70820 APPROVED
